sj-docx-1-jop-10.1177_02698811241248395 – Supplemental material for Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks

Supplemental material, sj-docx-1-jop-10.1177_02698811241248395 for Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks by Evan Cole Lewis, Alexandria Jaeger, Manesh Girn, Egiroh Omene, Madeline Brendle and Elena Argento in Journal of Psychopharmacology</p

A Previously Unrecognized Kanosamine Biosynthesis Pathway in <i>Bacillus subtilis</i>

The <i>ntd</i> operon in <i>Bacillus subtilis</i> is essential for biosynthesis of 3,3′-neotrehalosadiamine (NTD), an unusual nonreducing disaccharide reported to have antibiotic properties. It has been proposed that the three enzymes encoded within this operon, NtdA, NtdB, and NtdC, constitute a complete set of enzymes required for NTD synthesis, although their functions have never been demonstrated <i>in vitro</i>. We now report that these enzymes catalyze the biosynthesis of kanosamine from glucose-6-phosphate: NtdC is a glucose-6-phosphate 3-dehydrogenase, NtdA is a pyridoxal phosphate-dependent 3-oxo-glucose-6-phosphate:glutamate aminotransferase, and NtdB is a kanosamine-6-phosphate phosphatase. None of these enzymatic reactions have been reported before. This pathway represents an alternate route to the previously reported pathway from <i>Amycolatopsis mediterranei</i> which derives kanosamine from UDP-glucose